LabCompass

Lindsay Rosen

Medicine · The Ohio State University

OpenAlex ORCID
Early career · publishing since 2021
Chronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsPI3K/AKT/mTOR signaling in cancerLymphoma Diagnosis and TreatmentPhagocytosis and Immune Regulation

Publications

11

Citations

120

Est. group size

~14

Recurring co-author estimate

Active years

6

Publishing since 2021

Research summary
AI-generated

Lindsay Rosen's research focuses on blood cancers, particularly chronic lymphocytic leukemia (a slow-growing cancer of white blood cells) and lymphoma. Work includes studying treatment outcomes and side effects of targeted cancer drugs (such as Bruton tyrosine kinase inhibitors and brentuximab vedotin), as well as issues related to patient access to oral anticancer medications.

Chronic lymphocytic leukemia treatment outcomesLymphoma therapy and chemotherapy side effectsTargeted cancer drug safety (e.g., BTK inhibitors)Cancer drug access and healthcare deliveryHematologic malignancies

Publication output has been modest and irregular over the last decade, with no recorded output before 2021 and a fluctuating small number of papers per year since then.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.0/year recently
171819202021: 1 publication212022: 4 publications4222023: 3 publications23242025: 1 publication252026: 2 publications26
Recent publications
Publishes in
  • Blood×3
  • Leukemia×3
  • Circulation×2
  • Journal of Hematology & Oncology×1
  • Journal of the American College of Cardiology×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile